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Abstract
Background—Cancer risk prediction tools provide valuable information to clinicians but remain
computationally challenging. Many clinics find that Ca Gene or Hughes Risk Apps fit their needs
for easy- and ready-to-use software to obtain cancer risks; however, these resources may not fit all
clinics’ needs. The Hughes Risk Apps Group and Bayes Mendel Lab therefore developed a web
service, called “Risk Service", which may be integrated into any client software to quickly obtain
standardized and up-to-date risk predictions for Bayes Mendel tools (BRCAPRO, MMRpro,
PancPRO, and MelaPRO), the Tyrer-Cuzick IBIS Breast Cancer Risk Evaluation Tool, and the
Colorectal Cancer Risk Assessment Tool.
Findings—Software clients that can convert their local structured data into the HL7 XML-
formatted family and clinical patient history (Pedigree model) may integrate with the Risk
Service. The Risk Service uses Apache Tomcat and Apache Axis2 technologies to provide an all
Java web service. The software client sends HL7 XML information containing anonymized family
and clinical history to a Dana-Farber Cancer Institute (DFCI) server where it is parsed, interpreted,
and processed by multiple risk tools. The Risk Service then formats the results into an HL7 style
message and returns the risk predictions to the originating software client. Upon consent, users
may allow DFCI to maintain the data for future research. The Risk Service implementation is
exemplified through Hughes Risk Apps.
Conclusions—The Risk Service broadens the availability of valuable, up-to-date cancer risk
tools and allows clinics and researchers to integrate risk prediction tools into their own software
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interface designed for their needs. Each software package can collect risk data using its own
interface, and display the results using its own interface, while using a central, up-to-date risk
calculator. This allows users to choose from multiple interfaces while always getting the latest risk
calculations. Consenting users contribute their data for future research, thus building a rich multi-
center resource.
Keywords
Risk Prediction; BayesMendel; BRCAPRO; IBIS Breast Cancer Risk Evaluation Tool; Colorectal
Cancer Risk Assessment Tool; Web Service; Risk Service
Introduction
The widely used risk prediction tool BRCAPRO uses family and personal disease history to
calculate the risks of carrying mutations in the breast and ovarian cancer-associated genes
BRCA1 and BRCA2 and the risk of developing breast and ovarian cancer over time [1]. The
authors continually improve the tool as new literature is published regarding the prevalence
and penetrance of these genes, and their modifiers [2–7]. BRCAPRO applies the science of
Mendelian genetics and Bayesian approaches to calculating risks. The same approach has
been also applied to develop tools to evaluate the chance of carrying inheritable mutations
associated with pancreatic cancer, melanoma, colorectal cancer, and other cancers associated
with mismatch repair genes [8]. The complexity of these tools poses a challenge for practical
clinical use, as users are required to enter a potentially large amount of information to
evaluate the risk for a given family. This is addressed by implementation tools, which
provide user interfaces to simplify data entry, to provide visualizations of results, and to
support appropriate interpretation. Many clinics find that the freely available Ca Gene
(http://www4.utsouthwestern.edu/breasthealth/cagene/) or Hughes Risk Apps (HRA; http://
www.hughesriskapps.com/) applications fit their needs for easy and ready-to-use software to
obtain cancer risks; both tools provide a user friendly interface for oncology clinics to
collect family and clinical history and both immediately place risk assessments into the
clinician’s and/or genetic counselor’s hands [9–11]. Both systems have found a need to
continuously upgrade their version of BRCAPRO and other risk assessment tools. HRA has
addressed this through a web service known as “Risk Service.”
The Risk Service uses the concept of a web service, which as opposed to a web site, is
designed to interact with other software packages, not with humans. The algorithm,
guideline or knowledge base of web services (in this case risk prediction algorithms) is
installed on a server accessible through the cloud. The Risk Service alleviates from software
developers the onus of correctly coding risk prediction tools and allows them instead to
develop a convenient software interface to collect, and meaningfully present, information.
This report describes the data flow, risk algorithms currently offered, availability, and
implementation of the Risk Service (as exemplified through HRA).
Methods
Risk Service Architecture and Data Flow
The Risk Service resides on a Dana-Farber Cancer Institute (DFCI) server, receives Health
Level 7 (HL7) Pedigree Model [12] XML-formatted family and clinical history inputs, runs
all selected risk prediction tools, and returns the risk predictions (Figure 1). There is no
human readable interface. For the Risk Service to be practically functional, a software
package must create a user interface to collect family and clinical history and to display the
results of the calculations; the software interface is not restrictive to operating system, it may
be developed for android, iPhone, iPad, and other devices. That developed software
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communicates, via the HL7 message, with the Risk Service where the calculations are
actually performed.
The Risk Service software uses Tomcat, an all Java web server [13]. Within that framework,
Apache Axis2 is used as a toolkit for receiving and sending HL7 XML messages to and
from the server. HL7 XML input data is interpreted and parsed with XSLT, a specialized
XML translation language, and transformed for input into risk tools by an open-source
XSLT processor (Saxon, see Figure 2). The risk tools are run allowing for simultaneous
calls from different users while preserving each users' data in a safe and separate namespace;
they are run in parallel across multiple threads and/or CPUs, even for the same user, to
achieve a rapid response time.
The Risk Service requires users to obtain a license and valid user agreement (http://
bcb.dfci.harvard.edu/bayesmendel/riskservice.php) [14]. All academic institutions, research
institutions, and individual health care providers may use the Risk Service free of charge;
however, inclusion of the Risk Service into commercial products requires a commercial
license. In calling the Risk Service, the user either consents or declines consent for the
family history, clinical history, and results to be retained in a local MySQL database, in de-
identified form, and used for future research. At minimal risk, the de-identified family
history data, collected from multiple institutions, may provide an enormous benefit to the
scientific community by helping algorithm developers improve current risk prediction tools.
Each user is identified by a user license for the dual purpose of accounting for effects in
research and for disseminating the Risk Service.
Risk Prediction Tools
The Risk Service is tailored to clinicians and genetic counselors concerned with hereditary
cancer risk. Bayes Mendel tools – including BRCAPRO, MMRpro, PancPRO, and
MelaPRO – predict the risk of carrying highly penetrant genetic mutations associated with
disease. They use Mendelian laws explicitly and incorporate detailed family history
information (race, age, vital status, disease diagnoses, and age of diagnoses, and genetic
testing results for each relative), cancer specific data (ER, PR, Her2, CK14, CK5/6) and
some behavioral risk factors. BRCAPRO, for example, evaluates the risk of carrying a
deleterious BRCA1 and/or BRCA2 mutation and the risk of developing breast or ovarian
cancer over time [15–17]. Validations of these tools have been described [18–21].
The Risk Service also provides estimates for the IBIS Breast Cancer Risk Evaluation Tool
[22, 23] and the Colorectal Cancer Risk Assessment Tool (CCRAT) [24]. The IBIS Breast
Cancer Risk Evaluation Tool was developed to predict breast cancer risk and risk of
carrying a BRCA1 or BRCA2 mutation using family history information, in the presence of
high risk lesions in the proband (Atypia, LCIS) and additional behavioral and environmental
factors. It accounts for well-established risks of breast cancer including age at menarche,
parity, age at first childbirth, age at menopause, atypical hyperplasia, lobular carcinoma in
situ, height, and BMI. CCRAT focuses on predicting the risk of colorectal cancer; risks are
modified by family history and epi-environmental factors including health and wellness
factors, hormone therapy in women, screening for colorectal cancer, and past history of
polyps.
Implementation
As an example, we will discuss the implementation of the Risk Service through HRA. HRA
provides a user interface for the input of family history, genetic and clinical data (Figure 3),
stores the patient’s data into an SQL database, and then packages the data into a message
using the HL7-XML coding standard. That message is transmitted to the Risk Service.
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Receipt of the message triggers a basic call to the Risk Service – get Risk HL7() – which
calls each risk tool for each family member having sufficient data for the given risk tool. For
example, the counselee may be the only family member with sufficient information to call
CCRAT, whereas each family member in the pedigree may have sufficient data to run
BRCAPRO. A more succinct set of risk predictions may be requested by calling get Risk
HL7 Selected() (Figure 4). The Risk Service User Guide (Online Resource) provides the
codes to be used with the HL7 Family History input data. The Risk Service recognizes
multiple coding schemas, allowing software packages to choose which best fit their needs,
though the most commonly used is the Systematized Nomenclature of Medicine
(SNOMED). For a rudimentary example outside of HRA, a minimalistic client calling the
Risk Service is online and can be used to test HL7 input family history (http://
bayesmendel.dfci.harvard.edu/risk) [25].
Most model inputs into the risk tools are required, though some tool’s model inputs allow
for a value of “Unknown”, “missing”, or “NA”. That is, a value of NA is an allowed input
value, built into the design of the model. However, if a model input is required, and it is not
available, for certain reasonable situations the Risk Service may attempt to use (impute) an
appropriate value. For example, if a relative’s age of onset of breast cancer is missing, the
current age, if alive, or age at death is used. If the relative’s current age or age at death is
unknown, the age of onset of breast cancer is assumed to be age 50. All assumptions made
by the risk service about imputation of information appear in the output message section.
The output of the risk models are packaged into an HL7 XML results message, which is
returned to the originator of the message, in this case, the HRA instance that originated the
message. HRA will store these results in its SQL database and display the results to the user
in an intuitive visualization (Figure 5). User developed software will need to develop its own
display of the results.
To illustrate the power of this approach in March 2013, a new version of BRCAPRO that
now allows mastectomy as data inputs and families to have mixed ethnicities was installed
on the Risk Service. Immediately the 38 installations of HRA began using the latest model.
This occurred without any need for local upgrades of the software and was transparent to the
user.
Discussion
The Hughes Risk Apps Group and Bayes Mendel Lab jointly developed the Risk Service
with the intent to make freely available risk prediction tools for research and clinical use
[10, 26]. Running these tools via the Risk Service has the advantage of always using the
most up-to-date models without the need for local upgrades and re-installations. HRA
exemplifies a client that integrates the Risk Service to provide immediate risk predictions to
clinicians. Its user interface allows the collection of data by dynamically asking appropriate
sequential questions to collect relevant clinical, genetic and family history information and
produces intuitive visualizations that make it easy for the user to understand the information.
Ca Gene is another option to obtain risk predictions, but it does not currently integrate with
the Risk Service.
Most clinics find Ca Gene and HRA fit their needs for a ready and easy-to-use interface to
obtain immediate risk prediction estimates; however, these resources will not fit all clinics’
needs. The Risk Service is available, with a signed user agreement and license, to be
integrated with any client software developed to send and receive HL7 XML-formatted
family and clinical history. The HL7 format required by the Risk Service is consistent with
the health care industry standard and provides the broadest availability for the tools. While
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clinicians and patients benefit greatly from readily available risk predictions, a large pool of
multi-institutional family history data will be continually gathered. This again benefits
clinicians and patients as risk prediction tools are further developed and improved.
It is vital that we move toward the web service approach in clinical medicine. Medicine is
becoming more and more dependent on knowledge bases and Clinical Decision Support
(CDS). The current approach of having 600 Electronic Health Record vendors each develop
their own rendition of the knowledge bases and a CDS systems for each aspect of medical
care is an approach doomed to failure. We need Specialty Societies and Government to start
developing their guidelines, algorithms, and knowledge bases as machine readable web
services accessible to any CDS system. This approach is vital if we are to constrain the costs
of medical care while simultaneously improving quality care for all. The Risk Service was
developed as a prototype to show the value and utility of the web service approach.
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Fig 1.
Risk Service Data Flow. A software client collects data and packages it as an HL7 message
which the Risk Service can read and transmit to the Dana-Farber Cancer Institute server.
The server runs the prediction tools and returns the results to the software client as an HL7
message. If consented, data sent to the server are kept by DFCI for future research. (Clipart
used with permission from Microsoft).
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Fig 2.
Risk Service Data Architecture. The Risk Service uses Tomcat and Apache Axis2 to send
and receive HL7 XML messages to and from the Dana-Farber Cancer Institute Server. HL7
XML input is interpreted and parsed by XSLT and then transformed to be used by the risk
prediction tools.
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Fig 3.
Example User Interface (HRA) to Enter Family History Data. Arrow 1 shows tab to enter
disease data for the selected relative, arrow 2 shows tab to enter genetic testing data for the
selected relative, and arrow 3 shows area to enter vital status, age and other data for the
selected relative
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Fig 4.
Inputs For Requesting Predictions From Risk Service. get Risk HL7() is the most
comprehensive call to the Risk Service. It obtains risk predictions for all family members
with sufficient predictors for each given model. get Risk HL7 Selected() allows for
obtaining selected risk predictions and output.
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Fig 5.
Example User-Interface Displaying Risk Service Results. Using the data from BRCAPRO
via the Risk Service, HRA displays the risk of mutation for each family member.
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